Status:
COMPLETED
Obstructive Sleep Apnea and Acute Myocardial Infarction and the Role of Continuous Positive Airway Pressure (CPAP)Treatment
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Sleep Apnea, Obstructive
Acute Myocardial Infarction
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Specific Aim 1. To determine the prevalence of OSA in patients of first-time AMI in acute phase By screening patients of first-time, single-vessel disease, Killip I AMI, and successful revascularizat...
Detailed Description
Obstructive sleep apnea (OSA) is a major public health problem affecting at least 2-4% of middle-aged population. OSA resulted in hypoxia and sleep fragmentation, which resulted in neurocognitive dysf...
Eligibility Criteria
Inclusion
- First-time AMI
- s/p revascularization (successful primary PTCA for ischemia-related artery)
- Killip I
Exclusion
- Refuse to participate
- Require mechanical ventilation
- Having active neurologic event, severe obstructive airway disease and active infection, active malignancy
- Need sedative drug or narcotics during the study period within 3 days of PSG
- Participates other study at the same time
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00821210
Start Date
January 1 2008
End Date
November 1 2010
Last Update
December 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100